CSE:AGN - Post Discussion
Post by
yopmemama021 on Sep 20, 2022 4:18pm
AGN
Yesterday $AGN filed a request for orphan designation with the FDA for Ifenprodil as a treatment for IPF (chronic lung condition)
following positive results earlier this month from full data set of their phase 2 study - patients experienced improvements in frequency, severity of cough and reported improved quality of life
represents a novel first in class treatment for both IPF and chronic cough.
eyes on $AGN.c up 5.3% @ $5.52, mc $13.02 - tight share structure only 2.36M OS
$AGNPF
Be the first to comment on this post